Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-23-019252
Filing Date
2023-05-22
Accepted
2023-05-22 16:12:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A ocgn-20230522xdefa14a.htm DEFA14A 16756
2 GRAPHIC ocgnlogo.jpg GRAPHIC 27940
3 GRAPHIC remindernotice.jpg GRAPHIC 137035
4 GRAPHIC shankarsignature.jpg GRAPHIC 14244
5 GRAPHIC twitterimagea.jpg GRAPHIC 131009
  Complete submission text file 0001628280-23-019252.txt   445539
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36751 | Film No.: 23944543
SIC: 2836 Biological Products, (No Diagnostic Substances)